top of page
Browse by category
Search
Significant increase of weight loss drugs before bariatric surgery
There has been a 16-fold increase in the use of weight loss drugs among patients before metabolic and bariatric surgery, signalling an...
MBS associated with significant reductions in the rates of adverse hepatic and extrahepatic outcomes in patients with steatotic liver disease
In patients with steatotic liver disease (SLD), metabolic bariatric surgery (MBS) is associated with significant reductions in the rates...
RYGB is an effective approach for the management of obesity in selected adolescent patients
Roux-en-Y Gastric bypass (RYGB) is an effective approach for the management of obesity in selected adolescent patients, resulting in...
Endevica Bio reports co-agonism of the melanocortin-3 and -4 receptors drives robust weight loss
Endevica Bio has announced that the co-agonism of the melanocortin-3 and melanocortin-4 receptors (MC3/4R) drives robust weight loss,...
Bariatric surgery boosts short-term employment, but long-term gains uncertain
An international study led by Queensland University of Technology (QUT) researchers has found that bariatric surgery improves work...
PEACETIME: A new model of obesity care with a lasting impact
The PEACETIME project, led by Ulster University and supported by PEACEPLUS, a programme managed by the Special EU Programmes Body...
Browse by tag
bottom of page